Patient no. | Age | Duration of training | Pathology diagnosis | IF/TA | AS | protein | creatine | Vit D use | S (CK) | S (Ca) | S (Cr) | S (Cr) 1 year |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 26 | 7 years | ATN, microcalcifications | 30% | + | + | + | Oral | nd | 10.1 | 2.8 | 1.3 |
2 | 21 | 3 years | ATN, microcalcifications | 15% | + | + | + | Oral | nd | 10.0 | 3.8 | 1.0 |
3 | 21 | 4 years | ATN, microcalcifications | 0 | + | + | + | Oral | nd | 9.4 | 3.1 | 1.1 |
4 | 20 | 3 years | ATN, microcalcifications | 40% | + | + | + | Oral | nd | 10.0 | 2.6 | 1.2 |
5 | 23 | 4 years | ATN, microcalcifications | 20% | + | + | + | Oral | nd | 9.8 | 3.2 | 1.2 |
6 | 22 | 6 month | ATN, myoglobin casts | 30% | – | + | – | – | 6893 | nd | 8.6 | 1.0 |
7 | 19 | 1 month | ATN, myoglobin casts | 0 | – | – | – | – | 1254 | nd | 3.8 | 1.0 |
8 | 30 | 5 years | TIN | 10% | – | + | + | Oral | nd | 8.9 | 3.4 | 1.1 |
9 | 30 | 10 years | FSGS, NOS | 50% | + | + | + | Oral | nd | nd | 2.5 | ESRD |
10 | 40 | 20+ years | FSGS, perihilar | 0 | + | + | + | Oral | nd | nd | 1.3 | 1.3 |
11 | 32 | 8 years | PIGN | 0 | + | + | + | Oral | nd | nd | 1.9 | 1.2 |
12 | 49 | 20+ years | MGN | 5% | + | + | + | Oral | nd | nd | 1.4 | 1.1 |
13 | 26 | 5 years | MGN | 25% | + | + | + | Oral | nd | nd | 1.6 | 1.3 |
14 | 27 | 8 years | Nephrocalcinosis | 70% | + | + | + | INJ | nd | 13.1 | 1.9 | ESRD |
15 | 24 | 2 years | Nephrocalcinosis | 40% | + | + | + | INJ | nd | 12.8 | 2.0 | 3.4 |